Home Ligand-Binding Assays: Development, Validation, and Implementation in the Drug Development Arena by Masood N. Khan (Editor); John W. Findlay (Editor) (ISBN: 9780470041383)

Stock Photo: Cover May Be Different

Ligand-Binding Assays: Development, Validation, and Implementation in the Drug Development Arena Hardcover - 2009 - 1st Edition

Name: Ligand-Binding Assays: Development, Validation, and Implementation in the Drug Development Arena
Price: 120.16 GBP
Availability: InStock
Author: Masood N. Khan
ISBN: 9780470041383

by Masood N. Khan (Editor); John W. Findlay (Editor)

Browse more copies for sale ↓

From the rear cover

A consolidated and comprehensive reference on ligand-binding assays

Ligand-binding assays (LBAs) stand as the cornerstone of support for definition of the pharmaco-kinetics and toxicokinetics of macromolecules, an area of burgeoning interest in the pharmaceutical industry. Yet, outside of the Crystal City Conference proceedings, little guidance has been available for LBA validation, particularly for assays used to support macromolecule drug development. Ligand-Binding Assays: Development, Validation, and Implementation in the Drug Development Arena answers that growing need, serving as a reference text discussing critical aspects of the development, validation, and implementation of ligand-binding assays in the drug development field.

Ligand-Binding Assays covers essential topics related to ligand-binding assays, from pharmacokinetic studies, the development of LBAs, assay validation, statistical LBA aspects, and regulatory aspects, to software for LBAs and robotics and other emerging methodologies for LBAs. Highlights include:

A general discussion of challenges and proven approaches in the development of ligand-binding assays
More detailed examination of characteristics of these assays when applied to support of pharmacokinetic and toxicokinetic studies of compounds at different stages in the discovery or development timeline
A concise, but detailed, discussion of validation of ligand-binding assays for macromolecules
A practical approach to "fit-for-purpose" validation of assays for biomarkers, those molecules receiving increased attention as potentially demonstrating that the target chosen in discovery is being modulated by the candidate therapeutic, both in nonclinical and clinical studies

Written by a team of world-recognized authorities in the field, Ligand-Binding Assays provides key information to a broad range of practitioners, both in the pharmaceutical and allied industries and in related contract research organizations and academic laboratories and, perhaps, even in the field of diagnostics and clinical chemistry.

Details

Title Ligand-Binding Assays: Development, Validation, and Implementation in the Drug Development Arena
Author Masood N. Khan (Editor); John W. Findlay (Editor)
Binding Hardcover
Edition number 1st
Edition 1
Pages 432
Volumes 1
Language ENG
Publisher Wiley
Date 2009-11-01
Features Bibliography, Index, Table of Contents
ISBN 9780470041383 / 0470041382
Weight 1.65 lbs (0.75 kg)
Dimensions 9.3 x 6.3 x 0.9 in (23.62 x 16.00 x 2.29 cm)
Library of Congress subjects Drug Design, Protein Binding
Library of Congress Catalog Number 2009036489
Dewey Decimal Code 615.19

Media reviews

Citations

Scitech Book News, 03/01/2010, Page 115

About the author

Masood N. Khan, PhD, received his PhD from Aligarh Muslim University, India, and did postdoctoral research at the National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, in immunology and cell biology. He subsequently moved to McGill University, Montreal, Canada, and served as assistant professor in the Department of Medicine. In 1988, he established and successfully directed the Ligand-Binding Assay Bioanalytical (LBAB) Department at Phoenix International Life Sciences (currently MDS Life Sciences), Montreal. Dr. Khan is a founding member of the LBAB Focus Group at AAPS and has coauthored authoritative reviews on validation of LBA and biomarker assays. He has over 100 publications and presentations to his credit. He is currently the Chief Scientist at GLP Solutions Inc. in Rockville, Maryland.

John W. A. Findlay, PhD, earned his PhD from the University of Aberdeen, Scotland, and did postdoctoral work in organic and medicinal chemistry at the University of Virginia. He has extensive experience in successful drug development with several major pharmaceutical companies, particularly in the areas of bioanalysis and drug disposition. Dr. Findlay was a participant in the first AAPS/FDA workshop on bioanalytical method validation in 1990 and in subsequent AAPS/FDA workshops on this topic, as well as a coauthor of a guiding review article in this field published in 2000. Dr. Findlay has coauthored more than 140 original papers, reviews, book chapters, patents, and abstracts. He is currently a Senior Director in Clinical Pharmacology at Gilead Sciences in Durham, North Carolina.

More Copies for Sale

Ligand-Binding Assays: Development, Validation, and Implementation in the Drug Development Arena

by Masood N. Khan

New
Hardcover

Condition

New

Binding

Hardcover

ISBN 10 / ISBN 13

9780470041383 / 0470041382

Quantity Available

Seller

The Saint Bookstore

Southport, Merseyside, United Kingdom

Seller rating:

This seller has earned a 5 of 5 Stars rating from Biblio customers.

Item Price

$150.93

$12.50 shipping to USA

Show Details

Description:

Hardback. New. With increasing use of ligand-binding assays (LBAs) in the pharmaceutical industry, the need to critically evaluate technical and regulatory issues related to the use of these technologies has increased greatly.